OEL Fastrac Catalog

Absinth, also known as Artemisia absinthium, is a species of wormwood native to temperate regions of Europe, Asia and northern Africa. It grows naturally on uncultivated, arid ground, on rocky slopes and wastelands and it can also be cultivated in dry soil. The time of harvesting is important for the quality and the composition of the constituents. Metabolism processes change over the flowering period and ripening of the fruit. During the flowering period the concentration of bitter constituents increases. The main traditional indications for absinth include lack of appetite, dyspeptic complaints such as minor gastrointestinal spasms, repletion, flatulence, and spasmodic functional disorders of the biliary tract. Absinth formulations are available as an herbal substance for tea preparation, powdered herbal substance, expressed juice and tincture. Other traditional uses attributed to absinth include as an aromatic bitter, bitter tonic, anthelmintic, stomachic, antiparasitic, insecticide, antiseptic, choleretic, carminative, antiinflammatory, and mild antidepressant.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Absinth, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.